XKRX:323990 (Korea (the Republic of))
Â
Ordinary Shares
â‚©
15130.00
(-0.59%)
Aug 23
Business Description
Vaxcell-Bio Therapeutics
ISIN : KR7323990002
Share Class Description:
XKRX:323990: Ordinary SharesCompare
Compare
Traded in other countries / regions
323990.Korea IPO Date
2020-09-22Description
Vaxcell-Bio Therapeutics is a bio-technology company engaged in the development of Cell-based and Protein-based Immunotherapeutics for the treatment of cancer.
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Equity-to-Asset | 0.94 | |||||
Debt-to-Equity | 0.01 | |||||
Debt-to-EBITDA | -0.07 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 43.39 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -6.4 | |||||
3-Year EPS without NRI Growth Rate | -5.4 | |||||
3-Year FCF Growth Rate | -9.9 | |||||
3-Year Book Growth Rate | 1.5 |
Momentum Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 31.97 | |||||
9-Day RSI | 41.01 | |||||
14-Day RSI | 43.84 | |||||
6-1 Month Momentum % | -23.29 | |||||
12-1 Month Momentum % | -31.17 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 22.43 | |||||
Quick Ratio | 22.43 | |||||
Days Inventory | 1346.83 | |||||
Days Sales Outstanding | 6.13 | |||||
Days Payable | 76.63 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -32 | |||||
Shareholder Yield % | -0.05 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 52.84 | |||||
Operating Margin % | -16936.41 | |||||
Net Margin % | -18670.62 | |||||
FCF Margin % | -20764.56 | |||||
ROE % | -18.79 | |||||
ROA % | -18.08 | |||||
ROIC % | -28.9 | |||||
ROC (Joel Greenblatt) % | -64.46 | |||||
ROCE % | -14.03 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 6247.95 | |||||
PB Ratio | 4.47 | |||||
Price-to-Tangible-Book | 4.44 | |||||
EV-to-EBIT | -38.24 | |||||
EV-to-EBITDA | -40.25 | |||||
EV-to-Revenue | 5428.15 | |||||
EV-to-FCF | -26.32 | |||||
Price-to-Net-Current-Asset-Value | 7.36 | |||||
Earnings Yield (Greenblatt) % | -2.62 | |||||
FCF Yield % | -3.32 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Vaxcell-Bio Therapeutics Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil â‚©) | 55.876 | ||
EPS (TTM) (â‚©) | -478.303 | ||
Beta | 1.63 | ||
Volatility % | 53.77 | ||
14-Day RSI | 43.84 | ||
14-Day ATR (â‚©) | 844.912886 | ||
20-Day SMA (â‚©) | 15735.5 | ||
12-1 Month Momentum % | -31.17 | ||
52-Week Range (â‚©) | 13010 - 42873.685878 | ||
Shares Outstanding (Mil) | 22.96 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Vaxcell-Bio Therapeutics Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Vaxcell-Bio Therapeutics Stock Events
Event | Date | Price(â‚©) | ||
---|---|---|---|---|
No Event Data |
Vaxcell-Bio Therapeutics Frequently Asked Questions
What is Vaxcell-Bio Therapeutics(XKRX:323990)'s stock price today?
The current price of XKRX:323990 is â‚©15130.00. The 52 week high of XKRX:323990 is â‚©42873.69 and 52 week low is â‚©13010.00.
When is next earnings date of Vaxcell-Bio Therapeutics(XKRX:323990)?
The next earnings date of Vaxcell-Bio Therapeutics(XKRX:323990) is .
Does Vaxcell-Bio Therapeutics(XKRX:323990) pay dividends? If so, how much?
Vaxcell-Bio Therapeutics(XKRX:323990) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |